Jeff Cummings

Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer

Jermaine Coward, Hagen Kulbe, Probir Chakravarty et al. · Clinical Cancer Research · 2011 · 386 citations · Full text

Medicine, Oncology, Pharmacology +17

Evaluation of Circulating Tumor Cells and Serological Cell Death Biomarkers in Small Cell Lung Cancer Patients Undergoing Chemotherapy

Jianmei Hou, Alastair Greystoke, Lee Lancashire et al. · American Journal Of Pathology · 2009 · 237 citations · Full text

Medicine, Cell Biology, Oncology +14

Biomarker Utility of Circulating Tumor Cells in Metastatic Cutaneous Melanoma

Leila Khoja, Paul Lorigan, Cong Zhou et al. · Journal of Investigative Dermatology · 2012 · 137 citations · Full text

Medicine, Dermatology, Oncology +16

Phase I Trial of AEG35156 Administered as a 7-Day and 3-Day Continuous Intravenous Infusion in Patients With Advanced Refractory Cancer

Emma Dean, Duncan I. Jodrell, Kate Connolly et al. · Journal of Clinical Oncology · 2009 · 93 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Enhanced oxaliplatin-induced apoptosis following antisense Bcl-xl down-regulation is p53 and Bax dependent: Genetic evidence for specificity of the antisense effect

Richard L. Hayward, Janet S. Macpherson, Jeff Cummings et al. · Molecular Cancer Therapeutics · 2004 · 89 citations · Full text

Medicine, Oncology, Pharmacology +17